HutchMED (China) LIMITED Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
HutchMED (China) LIMITED (HMDCF) reported Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest of $1.38 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest · last filed 2026-03-05
- HutchMED (China) LIMITED comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-12-31 was $610.00K, a 22.69% decline year-over-year.
- HutchMED (China) LIMITED comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-09-30 was -$882.00K.
- HutchMED (China) LIMITED comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-06-30 was $556.00K, a 22.78% decline year-over-year.
- HutchMED (China) LIMITED comprehensive income (loss), net of tax, attributable to noncontrolling interest for the quarter ending 2019-03-31 was $1.34M, a 37.86% decline year-over-year.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.38M 20-F · filed 2026-03-05 | |||
| 2025-06-30 | $931.00K 6-K · filed 2025-08-07 | |||
| 2024-12-31 | $110.00K 20-F · filed 2026-03-05 | |||
| 2024-06-30 | $145.00K 6-K · filed 2025-08-07 | |||
| 2023-12-31 | -$39.00K 20-F · filed 2026-03-05 | |||
| 2023-06-30 | $573.00K 6-K · filed 2024-07-31 | |||
| 2022-12-31 | -$545.00K 20-F · filed 2025-03-19 | |||
| 2022-06-30 | -$496.00K 6-K · filed 2023-07-31 | |||
| 2021-12-31 | $28.03M 20-F · filed 2024-02-28 | |||
| 2021-06-30 | $3.29M 6-K · filed 2022-08-01 | |||
| 2020-12-31 | $11.41M 20-F · filed 2023-02-28 | |||
| 2020-06-30 | $1.30M 6-K · filed 2021-07-28 | |||
| 2019-12-31 | $610.00K derived: 20-F 12 month − 6-K 9 month · filed 2022-03-03 | -$272.00K derived: sum of 2 quarters · filed 2022-03-03 | $284.00K derived: sum of 3 quarters · filed 2022-03-03 | $1.62M 20-F · filed 2022-03-03 |
| 2019-09-30 | -$882.00K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$326.00K derived: sum of 2 quarters · filed 2020-07-30 | $1.01M 6-K · filed 2020-01-21 | $1.80M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-06-30 | $556.00K derived: 6-K 6 month − 6-K 3 month · filed 2020-07-30 | $1.89M 6-K · filed 2020-07-30 | $2.68M derived: sum of 3 quarters · filed 2021-03-04 | $1.59M derived: sum of 4 quarters · filed 2021-03-04 |
| 2019-03-31 | $1.34M 6-K · filed 2019-06-06 | $2.13M derived: sum of 2 quarters · filed 2021-03-04 | $1.03M derived: sum of 3 quarters · filed 2021-03-04 | $1.75M derived: sum of 4 quarters · filed 2021-03-04 |
| 2018-12-31 | $789.00K derived: 20-F 12 month − 6-K 9 month · filed 2021-03-04 | -$304.00K derived: sum of 2 quarters · filed 2021-03-04 | $416.00K derived: sum of 3 quarters · filed 2021-03-04 | $2.57M 20-F · filed 2021-03-04 |
| 2018-09-30 | -$1.09M derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | -$373.00K derived: sum of 2 quarters · filed 2020-01-21 | $1.78M 6-K · filed 2020-01-21 | |
| 2018-06-30 | $720.00K derived: 6-K 6 month − 6-K 3 month · filed 2019-07-30 | $2.87M 6-K · filed 2019-07-30 | ||
| 2018-03-31 | $2.15M 6-K · filed 2019-06-06 | |||
| 2017-12-31 | $5.03M 20-F · filed 2020-03-03 | |||
| 2017-06-30 | $2.37M 6-K · filed 2018-07-27 | |||
| 2016-12-31 | $1.43M 20-F · filed 2019-03-11 | |||
| 2016-06-30 | $1.79M 6-K · filed 2017-07-31 | |||
| 2015-12-31 | $1.73M 20-F · filed 2018-03-12 | |||
| 2014-12-31 | $2.94M 20-F · filed 2017-03-13 |